4SC AG Logo

4SC AG

Biopharmaceutical company with no products under development or operational business.

VSC | F

Overview

Corporate Details

ISIN(s):
DE000A3E5C40
LEI:
391200QOKN7LGVP0RQ86
Country:
Germany
Address:
Fraunhoferstr. 22, 82152 Planegg

Description

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-01-16 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
German HTML 6.4 KB
2025-01-16 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2025 bis zum 30.06.2025
German HTML 6.4 KB
2024-08-08 00:00
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2024 bis zum 30.0…
German HTML 101.6 KB
2023-11-27 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2023 bis zum 31.12.2023
German HTML 6.4 KB
2023-11-27 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
German HTML 6.3 KB
2023-08-10 00:00
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.01.2023 bis zum 30.06…
German HTML 100.3 KB
2022-12-20 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
German HTML 6.3 KB
2022-12-20 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
German HTML 6.4 KB
2022-11-30 00:00
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
German HTML 174.5 KB
2021-12-01 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
German HTML 6.4 KB
2021-12-01 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
German HTML 6.4 KB
2021-05-26 00:00
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
German HTML 4.2 KB
2021-02-04 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2021 bis zum 30.06.2021
German HTML 6.4 KB
2021-02-04 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2020 bis zum 31.12.2020
German HTML 6.4 KB
2020-05-08 00:00
Q1 statement / Q1 financial report 2020
English PDF 489.3 KB

Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 4SC AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 4SC AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA
Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.